GORE EXCLUDER AAA ENDOPROSTHESIS
Report
- Report Number
- 2017233-2011-00452
- Event Type
- Injury
- Date Received
- September 1, 2011
- Date of Event
- August 9, 2011
- Report Date
- September 1, 2011
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AK, US
- Reporter Occupation
- PHYSICIAN
Narratives
A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THE LOTS MET ALL PRE-RELEASE SPECIFICATIONS. ADDITIONAL DEVICES: 06854407/(B)(4), 8893483/(B)(4).
ON (B)(6), 2011, THE PT UNDERWENT THE FIRST PART OF A STAGED PROCEDURE FOR A JUXTARENAL ANEURYSM INVOLVING THE LEFT RENAL ARTERY WHERE TWO GORE EXCLUDER AAA ENDOPROSTHESES WERE IMPLANTED. ON (B)(6), 2011, THE PT UNDERWENT THE SECOND PART OF THE PROCEDURE FOR AN INFRARENAL ABDOMINAL AORTIC ANEURYSM AND BILATERAL ILIAC ANEURYSMS, AND WAS IMPLANTED WITH A GORE EXCLUDER AAA ENDOPROSTHESIS FEATURING C3 AND FIVE ADDITIONAL GORE EXCLUDER AAA ENDOPROSTHESES. ON (B)(6), 2011, THE PT UNDERWENT A FOLLOW-UP COMPUTED TOMOGRAPHY THAT REVEALED BOTH A PROXIMAL AND DISTAL TYPE I ENDOLEAK FROM DEVICES IMPLANTED IN (B)(6), 2011. ON (B)(6), 2011, THE PT UNDERWENT A REINTERVENTION WHERE THREE ADDITIONAL GORE EXCLUDER AAA ENDOPROSTHESES WERE IMPLANTED. FINAL ANGIOGRAPHY REVEALED NO ENDOLEAKS AND THE PT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG425 | 8856306 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R | PLAVIX| LIPITOR| METOPROLOL| PRILOSEC| PROZAC| AMLODIPINE| THE PATIENT IS ALSO ON DIALYSIS| CLONIDINE| ASPIRIN |